THI Medical Director Emerson C. Perin, MD, PhD, outlines Phase 3 Clinical Trial Results Demonstrate Promising Stem Cell Treatment Options...
THI Medical Director Emerson C. Perin, MD, PhD, outlines Phase 3 Clinical Trial Results Demonstrate Promising Stem Cell Treatment Options...
Visit U.S. News & World Report